These results, despite novelty, align with prior research demonstrating the capacity of PIP to intervene with CSCs in other breast cancer cell lines decreasing ALDH-1 levels and compromising mammosphere formation in hormone responsive MCF-7 and mesenchymal TNBC SUM 159 cells46. This evidence concerns the gene ALDH1A1 and breast carcinoma.